| Authors: |
Rutella S; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK.; Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, Nottinghamshire, UK., Cannarile MA; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Penzberg, Germany., Gnjatic S; Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Gomes B; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Basel, Switzerland., Guinney J; Sage Bionetworks, Seattle, Washington, USA., Karanikas V; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Zurich, Switzerland., Karkada M; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA., Kirkwood JM; Department of Medicine, Division of Hematology/ Oncology, University of Pittsburgh School of Medicine and Melanoma Center at UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Kotlan B; National Institute of Oncology, Budapest, Hungary., Masucci GV; Department Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Meeusen E; CancerProbe Pty Ltd, Prahran, Victoria, Australia., Monette A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Naing A; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Thorsson V; Institute for Systems Biology, Seattle, Washington, USA., Tschernia N; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Wang E; Allogene Therapeutics, South San Francisco, California, USA., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Wyant TL; Biolojic Design Inc, Cambridge, Massachusetts, USA., Cesano A; ESSA Pharma Inc, South San Francisco, California, USA acesano@essapharma.com. |
